Author: alacrisadmin

Alacris Theranostics: Finalist of the „Innovationspreises der deutschen Wirtschaft 2015“

Alacris is proud to be one of the four finalists in the category „Start-Up-Companies“. A committee of representatives from industry and science considered the 200 applications. Criteria for the award alongside the level of innovation are marketability, innovation management and sustainability of the business concept. The oldest innovation award in the world is awarded in […]

more...

Alacris among the Finalists of the STEP Award 2015

The STEP Award is a competition to reward innovative and high-growth companies in Germany, Austria and Switzerland and to give companies in the growth phase impetus for their successful development. Accordingly growth industries like pharma and life science are in the focus of the competition. We are delighted to have convinced the jury with our […]

more...

Alacris wins the Deutsche Innovationspreis 2015

The Deutsche Innovationspreis 2015 was awarded in Munich on Friday, April 24th. Alacris is the proud winner in the category Small and Medium Sized Enterprises.Our innovation ModCellTM convinced the jury. They agree with us that our systems biology approach not only helps physicians and clinics to find the right drug for the right patient. It […]

more...

European consortium to validate blood-based biomarkers for cancer

Alacris is one of the partners of CANCER-ID, a newly formed European consortium funded by the Innovative Medicines Initiative (IMI). CANCER-ID consists of currently 33 partners from 13 countries aiming at the establishment of standard protocols for and clinical validation of blood-based biomarkers. The consortium brings together experts from academic and clinical research, innovative Small-to-Medium […]

more...

Alacris Theranostics and Max Planck Institute for Molecular Genetics collaborate in TREGeneration Consortium

Berlin, 27th February 2015 – The teams led by Marie-Laure Yaspo at the Max Planck Institute for Molecular Genetics and by Hans Lehrach at Alacris Theranostics GmbH in Berlin are partners in a European consortium that recently obtained funding from the European Commission under the Horizon 2020 program to participate in a clinical research project […]

more...

Alacris Theranostics: Finalist of the „Innovationspreises der deutschen Wirtschaft 2015“

Alacris is proud to be one of the four finalists in the category „Start-Up-Companies“. A committee of representatives from industry and science considered the 200 applications. Criteria for the award alongside the level of innovation are marketability, innovation management and sustainability of the business concept. The oldest innovation award in the world is awarded in […]

more...